OnKure Therapeutics, Inc. OKUR Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s operating income?
- OnKure Therapeutics, Inc. (OKUR) reported operating income of -$15.62M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s operating income changed year-over-year?
- OnKure Therapeutics, Inc.'s operating income increased by 8.1% year-over-year, from -$17M to -$15.62M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s operating income?
- Over 3 years (2021 to 2025), OnKure Therapeutics, Inc.'s operating income has grown at a 16.5% compound annual growth rate (CAGR), from -$39.82M to -$62.95M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.